The clinical study of intercostal nerve pulsed radiofrequency in postherpetic neuralgia

ISRCTN ISRCTN25588650
DOI https://doi.org/10.1186/ISRCTN25588650
Secondary identifying numbers N/A
Submission date
10/06/2010
Registration date
21/06/2010
Last edited
26/07/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr MA Ke
Scientific

Department of Anesthesiology
Xinhua Hospital
Shanghai Jiaotong University School of Medicine
1665 Kongjiang Road
Shanghai
200092
China

Email macoo74@hotmail.com

Study information

Study designProspective double blind randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details below to request a patient information sheet
Scientific titleThe clinical study of intercostal nerve pulsed radiofrequency in postherpetic neuralgia: A randomised controlled trial.
Study objectives1. That pulsed radiofrequency of intercostals nerve was effective and safe in chronic refractory postherpetic neuralgia (PHN) patients
2. This pulsed radiofrequency can improve the quality of life and reduce the oral pain-related drugs dosage of PHN patients
Ethics approval(s)1. The ethics committee of Xinhua Hospital (affiliated to Shanghai Jiaotong Universty School of Medicine) approved on the 16th of March 2010 (ref: 2010-002)
2. The ethics committee of Shanghai Sixth People's Hospital approved on the 28th of October 2009 (ref: 2009-96)
Health condition(s) or problem(s) studiedPostherpetic neuraglia (PHN)
InterventionPatients were randomised to receive one of the following treatments, once a week for 3 weeks:
1. Pulsed radiofrequency (42 degree, 120 second) of the intercostal nerve (Thoracic 1 to T12 level)
2. Sham procedure, apparatus was left in test mode without the appropriate power output
Intervention typeOther
Primary outcome measure1. Visual Analogue Scale (VAS) score, measured at baseline, days 3, 7, 14, 30 and 60, 6 months and 1 year
2. Flare pain per day during days 3, 7, 14, 30, 60 and at 6 months
3. Neurometer CPT/C (Neurotron, Inc) to measure three fiber function
4. SF-36 at baseline, 2 months, 6 months and 1 year following-up
Secondary outcome measures1. Need to PRF again or other invasive operation at 2 day, 6 month or 1 year following-up
2. Dosage of rescue drug consumed per week at the end of treatment and after 4 weeks follow-up - including Tramadol and/or acetaminophen - and the dosage of combined drug, anti-depressive drug (amitriptyline)
3. Presence, frequency and duration of adverse effects at 7, 14, 30, and 60 days
Overall study start date22/02/2008
Completion date28/05/2011

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participants96
Key inclusion criteria1. Age greater than 60 years
2. PHN history is longer than 3 months
3. Pain on Visual Analogue Scale (VAS) >3 (0-10 VAS scale)
4. PHN affected nerve sectors were thoracic nerves from T1 to T12 level
5. Refractory to formal treatment such as antiepileptic medicine, antidepressants, opioids and physical treatments and epidural block
Key exclusion criteria1. Exclusion criteria included withdraws from the study
2. Poor effect, intolerant to the study
3. Uncooperative and unable to finish the self evaluation (VAS, QOL and SF-36)
4. Coagulation disturbances
5. Allergies to local anaesthetic
6. Malignancy
Date of first enrolment22/02/2008
Date of final enrolment28/05/2011

Locations

Countries of recruitment

  • China

Study participating centre

Department of Anesthesiology
Shanghai
200092
China

Sponsor information

Xinhua Hospital (China)
Hospital/treatment centre

Department of Anesthesiology
Shanghai Jiaotong University School of Medicine
1665 Kongjiang Road
Shanghai
200092
China

Email marke72@163.com
ROR logo "ROR" https://ror.org/04dzvks42

Funders

Funder type

Government

Shanghai Education Funding Committee (China)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2013 Yes No